Tikva Allocell
News,Biotech / MedTech,Singapore
Singapore’s Tikva Allocell raises $8M in Series A financing led by Kantharos Capital
Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.
July 23, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026




